Windward Bio's Omar Khwaja holds 642,136 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
As of November 12, 2026, Windward Bio Group AG (WWB) Chief Medical Officer Omar Khwaja reported direct ownership of 642,136 common shares and an option covering 318,830 common shares.
The option has a $0.02 exercise price and expires April 30, 2036. It vested or will vest in 36 equal monthly installments on the last day of each relevant month, beginning April 30, 2026, subject to Khwaja’s continuous service on each vesting date.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Holding | Employee Share Option (Right to Buy) F2, F1 | -- | -- | -- |
| Holding | Common Shares | -- | -- | -- |
Footnotes (2)
- F1. This option vested or will vest in 36 equal monthly installments on the last day of the relevant month commencing on April 30, 2026, subject to the Reporting Person's continuous service as of each such vesting date.
- F2. The exercise price is in US Dollars and reflects the conversion of CHF to USD at an exchange rate of $1.122 to CHF 1.00 as of November 6, 2026.
Key Figures
Key Terms
exercise price financial
monthly installments technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What are the terms of Omar Khwaja’s WWB option?
AI-generated analysis. How Rhea-AI works. Not financial advice.